These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23357253)

  • 1. Drug-inorganic-polymer nanohybrid for transdermal delivery.
    Kim MH; Park DH; Yang JH; Choy YB; Choy JH
    Int J Pharm; 2013 Feb; 444(1-2):120-7. PubMed ID: 23357253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inorganic-polymer nanohybrid carrier for delivery of a poorly-soluble drug, ursodeoxycholic acid.
    Choi G; Lee JH; Oh YJ; Choy YB; Park MC; Chang HC; Choy JH
    Int J Pharm; 2010 Dec; 402(1-2):117-22. PubMed ID: 20933070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.
    Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
    Colloids Surf B Biointerfaces; 2010 Dec; 81(2):412-21. PubMed ID: 20719479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and Evaluation of Hyaluronic Acid-Coated Flurbiprofen-Layered Double Hydroxide Ocular Drug Delivery System.
    Gu D; Pan H; Xu S; Chen W; Zhu R; Jiang W; Pan W
    AAPS PharmSciTech; 2022 Oct; 23(8):287. PubMed ID: 36266593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermal flurbiprofen nanosuspensions: Optimization with design of experiment approach and in vitro evaluation.
    Oktay AN; Karakucuk A; Ilbasmis-Tamer S; Celebi N
    Eur J Pharm Sci; 2018 Sep; 122():254-263. PubMed ID: 29981401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zn-Al-NO(3)-layered double hydroxides with intercalated diclofenac for ocular delivery.
    Cao F; Wang Y; Ping Q; Liao Z
    Int J Pharm; 2011 Feb; 404(1-2):250-6. PubMed ID: 21093561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocomposites of 2-arylpropionic acid drugs based on Mg-Al layered double hydroxide for dissolution enhancement.
    Berber MR; Minagawa K; Katoh M; Mori T; Tanaka M
    Eur J Pharm Sci; 2008 Nov; 35(4):354-60. PubMed ID: 18789388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen.
    González-Mira E; Nikolić S; García ML; Egea MA; Souto EB; Calpena AC
    J Pharm Sci; 2011 Jan; 100(1):242-51. PubMed ID: 20575052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of skin permeation of flurbiprofen via its transdermal patches using isopulegol decanoate (ISO-C10) as an absorption enhancer: pharmacokinetic and pharmacodynamic evaluation.
    Chen Y; Quan P; Liu X; Guo W; Song W; Cun D; Wang Z; Fang L
    J Pharm Pharmacol; 2015 Sep; 67(9):1232-9. PubMed ID: 25994482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery.
    Kawadkar J; Pathak A; Kishore R; Chauhan MK
    Drug Dev Ind Pharm; 2013 Apr; 39(4):569-78. PubMed ID: 22639934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-laminated metal hydroxide nanocontainers for oral-specific delivery for bioavailability improvement and treatment of inflammatory paw edema in mice.
    Kankala RK; Kuthati Y; Sie HW; Shih HY; Lue SI; Kankala S; Jeng CC; Deng JP; Weng CF; Liu CL; Lee CH
    J Colloid Interface Sci; 2015 Nov; 458():217-28. PubMed ID: 26225492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does stereochemistry influence transdermal permeation of flurbiprofen through the rat skin?
    Valentová J; Bauerová K; Farah L; Devínsky F
    Arch Dermatol Res; 2010 Oct; 302(8):635-8. PubMed ID: 20582424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation.
    Han F; Yin R; Che X; Yuan J; Cui Y; Yin H; Li S
    Int J Pharm; 2012 Dec; 439(1-2):349-57. PubMed ID: 22989987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pluronic lecithin organogel as a topical drug delivery system.
    Pandey M; Belgamwar V; Gattani S; Surana S; Tekade A
    Drug Deliv; 2010 Jan; 17(1):38-47. PubMed ID: 22747074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivariate optimization of formulation variables influencing flurbiprofen proniosomes characteristics.
    Zidan AS; Mokhtar M
    J Pharm Sci; 2011 Jun; 100(6):2212-21. PubMed ID: 21259237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glyceryl monooleyl ether-based liquid crystalline nanoparticles as a transdermal delivery system of flurbiprofen: characterization and in vitro transport.
    Uchino T; Murata A; Miyazaki Y; Oka T; Kagawa Y
    Chem Pharm Bull (Tokyo); 2015; 63(5):334-40. PubMed ID: 25948327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular delivery of flurbiprofen based on Eudragit(®) E-flurbiprofen complex dispersed in aqueous solution: preparation, characterization, in vitro corneal penetration, and ocular irritation.
    Quinteros DA; Tártara LI; Palma SD; Manzo RH; Allemandi DA
    J Pharm Sci; 2014 Dec; 103(12):3859-3868. PubMed ID: 25294798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ibuprofen intercalation and release from different layered double hydroxides.
    Gaskell EE; Ha T; Hamilton AR
    Ther Deliv; 2018 Sep; 9(9):653-666. PubMed ID: 30189806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered Cellular Uptake and Controlled Drug Delivery Using Two Dimensional Nanoparticle and Polymer for Cancer Treatment.
    Senapati S; Shukla R; Tripathi YB; Mahanta AK; Rana D; Maiti P
    Mol Pharm; 2018 Feb; 15(2):679-694. PubMed ID: 29298488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enteric-coated layered double hydroxides as a controlled release drug delivery system.
    Li B; He J; Evans DG; Duan X
    Int J Pharm; 2004 Dec; 287(1-2):89-95. PubMed ID: 15541916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.